Protective immune response against Rhodococcus equi : An innate immunity‐focused review
Equine Veterinary Journal · 2025-05 · 57 (3) · 563-586
DOI: 10.1111/evj.14214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Equine Veterinary Journal, online erschienen am 11.09.2024. Verfasst von Bibiana Petri da Silveira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, Texas A&M University, School of Veterinary Medicine & Biomedical …. Hauptthemen laut MEDLINE: Rhodococcus equi, Actinomycetales Infections, Immunity, Innate, Horse Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 253 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Link Equine Research Endowment, National Institute of Food and Agriculture, NIAID NIH HHS.
Abstract (Originalsprache)
Rhodococcus equi causes pyogranulomatous pneumonia in foals and immunocompromised people. Despite decades of research efforts, no vaccine is available against this common cause of disease and death in foals. The purpose of this narrative review is to summarise the current understanding of interactions between R. equi and the host innate immune system, to describe features of the immune response that are associated with resistance or susceptibility to R. equi infection, and help guide strategies for developing novel approaches for preventing R. equi infections. Virulence of R. equi in foals has been attributed to the virulence associated protein A which allows intracellular survival in macrophages by preventing acidification of R. equi ‐containing vacuole. Additionally, foal susceptibility to R. equi infection is associated with immaturity and naivety of innate and adaptive immune systems, while adult horses with fully functional immune system are resistant to pneumonia. Specific interaction between R. equi and innate immune cells can result in bacterial survival or death; learning how to manipulate these responses to control infection is critical to prevent pneumonia in foals. Administration of live vaccines and stimulation of innate immune responses appears to improve foals' immune response and has the potential to overcome the challenges of foal active vaccination and elicit protection against pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, Texas A&M University, School of Veterinary Medicine & Biomedical Sciences, College Station, Texas, USA.
- Department of Veterinary Pathobiology, Texas A&M University, School of Veterinary Medicine & Biomedical Sciences, College Station, Texas, USA.
- Department of Microbial Pathogenesis & Immunology, Texas A&M University, School of Medicine, College Station, Texas, USA.
ORCID-Profile: Bibiana Petri da Silveira, Noah D Cohen, Sara D Lawhon, Robert O Watson, Angela I Bordin
Förderung
- Link Equine Research Endowment
- National Institute of Food and Agriculture
- NIAID NIH HHS
- Grayson-Jockey Club Research Foundation
- Glenn Blodgett Chair in Equine Studies (NCD)
- National Council on Disability
Zitieren
APA
da Silveira, B. P., Cohen, N. D., Lawhon, S. D., Watson, R. O., & Bordin, A. I. (2025). Protective immune response against Rhodococcus equi : An innate immunity‐focused review. Equine Veterinary Journal, 57(3), 563-586. https://doi.org/10.1111/evj.14214
Vancouver
da Silveira BP, Cohen ND, Lawhon SD, Watson RO, Bordin AI. Protective immune response against Rhodococcus equi : An innate immunity‐focused review. Equine Veterinary Journal. 2025;57(3):563-586. doi:10.1111/evj.14214
BibTeX
@article{daSilveira2025,
author = {da Silveira, Bibiana Petri and Cohen, Noah D and Lawhon, Sara D and Watson, Robert O and Bordin, Angela I},
title = {Protective immune response against Rhodococcus equi : An innate immunity‐focused review},
journal = {Equine Veterinary Journal},
year = {2025},
volume = {57},
number = {3},
pages = {563--586},
doi = {10.1111/evj.14214}
}
EUVIMED